Seiji Matsuoka
Wako, 3510198, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Discovery of potent substrate-type lysine methyltransferase G9a inhibitors for the treatment of sickle cell disease.
Journal: European journal of medicinal chemistry
Published: January 27, 2025
Structure-based development of novel substrate-type G9a inhibitors as epigenetic modulators for sickle cell disease treatment.
Journal: Bioorganic & medicinal chemistry letters
Published: April 24, 2024
Synergistic involvement of the NZF domains of the LUBAC accessory subunits HOIL-1L and SHARPIN in the regulation of LUBAC function.
Journal: Cell death & disease
Published: January 12, 2024
Identification of small-molecule inhibitors against the interaction of RNA-binding protein PSF and its target RNA for cancer treatment.
Journal: PNAS nexus
Published: May 25, 2023
A Novel Class of HIV-1 Inhibitors Targeting the Vpr-Induced G2-Arrest in Macrophages by New Yeast- and Cell-Based High-Throughput Screening.
Journal: Viruses
Published: April 09, 2022
Visit-to-visit blood pressure variability in children and adolescents with renal disease.
Journal: Clinical and experimental nephrology
Published: January 25, 2018
Masked Isolated Nocturnal Hypertension in Children and Young Adults.
Journal: Pediatric cardiology
Published: June 16, 2017
White-Coat and Reverse White-Coat Effects Correlate with 24-h Pulse Pressure and Systolic Blood Pressure Variability in Children and Young Adults.
Journal: Pediatric cardiology
Published: May 01, 2015
Spectomycin B1 as a novel SUMOylation inhibitor that directly binds to SUMO E2.
Journal: ACS chemical biology
Published: October 23, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026